| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Morning-after pill may go over the counter

The Plan B One-Step emergency contraceptive box will be available without a prescription to all girls of reproductive age if a federal judge's ruling is upheld.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

By The Associated Press
Saturday, April 6, 2013, 12:01 a.m.

WASHINGTON — The morning-after pill might become as easy to buy as aspirin.

In a scathing rebuke accusing the Obama administration of letting election-year politics trump science, a federal judge ruled on Friday that there should be no age restrictions on the sale of emergency contraception without a doctor's prescription.

Today buyers must prove at the pharmacy that they are 17 or older; everyone else must see a doctor first. U.S. District Judge Edward Korman of New York blasted the government's decision on age limits as “arbitrary, capricious and unreasonable,” and ordered an end to the restrictions within 30 days.

The Justice Department was evaluating whether to appeal, and spokeswoman Allison Price said there would be a prompt decision.

President Obama had supported the 2011 decision setting age limits, and White House spokesman Jay Carney said on Friday that the president has not changed his position. “He believes it was the right common-sense approach to this issue,” Carney said.

If the court order stands, Plan B One-Step and its generic versions could move from behind pharmacy counters out to drugstore shelves — ending a decade-plus struggle by women's groups for easier access to these pills, which can prevent pregnancy if taken soon enough after unprotected sex.

Saying the sales restrictions can make it hard for women of any age to buy the pills, Korman described the Obama administration's decision, in the year before the 2012 presidential and congressional elections, as “politically motivated, scientifically unjustified and contrary to agency precedent.”

Women's health specialists hailed the ruling.

“It has been clear for a long time that the medical and scientific community think this should be fully over-the-counter and is safe for women of all ages to use,” said Dr. Susan Wood, who resigned as the Food and Drug Administration's women's health chief in 2005 to protest the Bush administration's foot-dragging over Plan B.

Half the nation's pregnancies every year are unintended. Doctors groups say more access to morning-after pills — by putting them near the condoms and spermicides — could cut those numbers. They believe there is little risk of overuse, as the pills cost $40 to $50 apiece.

Social conservatives criticized the ruling.

“There is a real danger that Plan B may be given to young girls, under coercion or without their consent,” said Anna Higgins of the Family Research Council. “The involvement of parents and medical professionals acts as a safeguard for these young girls. However, today's ruling removes these common-sense protections.”

Absent an appeal or a government request for more time to prepare one, the ruling would take effect in 30 days, meaning over-the-counter sales could start then.

The morning-after pill contains a higher dose of the female progestin hormone than found in regular birth control pills. Taking it within 72 hours of rape, condom failure or just forgetting regular contraception can cut the chances of pregnancy by up to 89 percent. It works best within the first 24 hours.

If a woman is pregnant, the pill has no effect. It prevents ovulation or fertilization of an egg.

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read Business Headlines

  1. Cleveland district, including Pittsburgh, shows moderate economic growth in latest Beige Book report from Fed
  2. Esmark sues Slovakian businessman for $100M, alleges sabotaged deal
  3. McDonald’s to ban chicken suppliers from antibiotics used in human medicine
  4. Exxon CEO: Low oil prices here to stay
  5. Transcripts show Fed’s fear of big bank aid
  6. Labor Department, nonprofit studies urge workplace injury system reform
  7. Sales, profit rebound as American Eagle Outfitters returns to roots
  8. Impact fees garner support from state community leaders
  9. Concurrent Technologies focuses on developing batteries for renewable energy, electric cars
  10. Mylan closes $5.3B tax-lowering deal with Abbott Labs
  11. Oilfield employee cutbacks may benefit long-haul trucking